Abstract
Updated 18-Month Results from Dasfree: A Study Evaluating Dasatinib Discontinuation in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) and Deep Molecular Response (DMR)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have